Pilot Study - Monitoring the Nasal Microbiome and Viral Respiratory Infections in Newborn Hospitalized in Neonatalogy. (NEONATMICROBIO)

Caen University Hospital

Status: Completed

Conditions: Newborn; Infection

Treatments: Other: Nasal Swab

Study type: Interventional

Funder types: Other

Identifiers

NCT06389383

22-0182

Details and patient eligibility

About

The objective of our study is therefore to study the evolution of the respiratory microbiome of hospitalized newborns, its interaction with viral infections and their impacts on the evolution of newborns.

Enrollment: 38 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Newborn hospitalized in intensive care or neonatal intensive care.
• Whose parents were able to be informed of the study and who signed consent.
• Parents affiliate to the social security system

Exclusion criteria

• Refusal of parental consent
• Parents who are minors or under guardianship, curatorship, safeguard of justice or legal protection.
• Newborn having already left the hospital/returned home before inclusion
• Hospitalization beyond the first 48 hours of life
• Only palliative care.

Trial design

Primary purpose: Basic Science

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

38 participants in 1 patient group

Nasal swab

Other group

Description:

* Nasal swab once a week for the duration of the stay in intensive care unit/intensive care (procedure already carried out routinely to detect nasal staphylococcus once a week). * Nasal swab every 14 days when the newborn is hospitalized in routine care/kangaroo unit/hospitalization at home

Treatment:

Other: Nasal Swab